Status:
COMPLETED
Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Gastroesophageal Reflux
Eligibility:
All Genders
1-12 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to provide additional information on safety and tolerability after multiple does of pantoprazole. Only patients who successfully completed the 3001B3-331 study (NCT0036260...
Eligibility Criteria
Inclusion
- Successful completion of the 3001B3-331 study (NCT00362609) or 3001B3-333 study (NCT00259012) Study.
Exclusion
- Patients requiring chronic use of warfarin, carbamepazine, or phenytoin.
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT00868296
Start Date
March 1 2006
End Date
March 1 2008
Last Update
May 4 2010
Active Locations (71)
Enter a location and click search to find clinical trials sorted by distance.
1
Phoenix, Arizona, United States, 85006
2
Loma Linda, California, United States, 92354
3
Oakland, California, United States, 94609-1809
4
Orange, California, United States, 92868